Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BioXclude vs Mem-Lok for Socket Preservation
NCT03422692Phase 1Completed
- Sponsor
- University of Kentucky
- Start
- Oct 2013
- Primary completion
- Oct 2015
- Countries
- 1
01
Overview
Phase 1, randomised trial (2 arms), sponsored by University of Kentucky. Primary endpoint: Bone quality at 19.5 weeks. Started Oct 2013; status: completed.
Beyond the preview
Go deeper on NCT03422692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03422692.